These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34568267)

  • 21. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
    Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015395. PubMed ID: 36126225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany.
    Sorg AL; Hufnagel M; Doenhardt M; Diffloth N; Schroten H; von Kries R; Berner R; Armann J
    Eur J Pediatr; 2022 Oct; 181(10):3635-3643. PubMed ID: 35962242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between living in municipalities with high crowding conditions and poverty and mortality from COVID-19 in Mexico.
    Ríos V; Denova-Gutiérrez E; Barquera S
    PLoS One; 2022; 17(2):e0264137. PubMed ID: 35192660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Characteristics of Coronavirus Disease (COVID-19) in Mexican Children and Adolescents.
    Flores-Alanis A; Saldaña-Ahuactzi Z; Parra-Ortega I; López-Ramírez P; Salazar-García M; Alemán-García YP; Cruz-Rangel A; Moreno-Paredes A; Diaz-Rojas A; Maldonado-Bernal C; Quevedo-Moran J; Luna-Pineda VM
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comorbidities associated with maternal mortality from COVID-19 in Mexico.
    López-Rodríguez G; Galván M; Valencia ÓG
    Gac Med Mex; 2021; 157(6):599-603. PubMed ID: 35108243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographics, comorbidities, and laboratory parameters in hospitalized patients with SARS-CoV2 infection at a community hospital in rural Pennsylvania.
    Pachpande V; Senapathi SHV; Williams K; Chai S; Mandal S; Prabhu S
    PLoS One; 2022; 17(4):e0267468. PubMed ID: 35476841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: a population-based study in northeastern Italy.
    Rugge M; Zorzi M; Guzzinati S; Stocco C; Avossa F; Del Zotto S; Clagnan E; Bricca L; Dal Maso L; Serraino D
    Tumori; 2023 Feb; 109(1):38-46. PubMed ID: 35130777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicity study of air pollution and mortality in Latin America (the ESCALA study).
    Romieu I; Gouveia N; Cifuentes LA; de Leon AP; Junger W; Vera J; Strappa V; Hurtado-Díaz M; Miranda-Soberanis V; Rojas-Bracho L; Carbajal-Arroyo L; Tzintzun-Cervantes G;
    Res Rep Health Eff Inst; 2012 Oct; (171):5-86. PubMed ID: 23311234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
    Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
    Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 pandemic and Construction Industry: insights from Italian data.
    Riccò M
    Acta Biomed; 2022 Jul; 93(3):e2022233. PubMed ID: 35775779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors.
    Márquez-González H; Méndez-Galván JF; Reyes-López A; Klünder-Klünder M; Jiménez-Juárez R; Garduño-Espinosa J; Solórzano-Santos F
    Front Public Health; 2021; 9():660114. PubMed ID: 34386471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological prevalence of SARS-CoV-2 infection and associated factors in healthcare workers in a "non-COVID" hospital in Mexico City.
    Cruz-Arenas E; Cabrera-Ruiz E; Laguna-Barcenas S; Colin-Castro CA; Chavez T; Franco-Cendejas R; Ibarra C; Perez-Orive J
    PLoS One; 2021; 16(8):e0255916. PubMed ID: 34383842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of SARS-CoV2 infection on mortality and hospitalization in nursing home residents during the "Omicron era".
    Bulgaresi M; Rivasi G; Tarantini F; Espinoza Tofalos S; Del Re LM; Salucci C; Turrin G; Barucci R; Bandinelli C; Fattorini L; Borchi D; Betti M; Checchi S; Baggiani L; Collini F; Lorini C; Bonaccorsi G; Ungar A; Mossello E; Benvenuti E
    Aging Clin Exp Res; 2023 Jun; 35(6):1393-1399. PubMed ID: 37103663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of 4963 deaths associated with COVID-19 during three pandemic waves in a Latin American city with a high mortality rate, 2020-2021.
    Viana-Cárdenas E; Triana A; Mendoza H; Buendia E; Viasus D
    Trop Med Int Health; 2022 Feb; 27(2):158-164. PubMed ID: 34873803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis.
    Gurdasani D; Bhatt S; Costello A; Denaxas S; Flaxman S; Greenhalgh T; Griffin S; Hyde Z; Katzourakis A; McKee M; Michie S; Ratmann O; Reicher S; Scally G; Tomlinson C; Yates C; Ziauddeen H; Pagel C
    J R Soc Med; 2021 Nov; 114(11):513-524. PubMed ID: 34723680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who is most at risk of dying if infected with SARS-CoV-2? A mortality risk factor analysis using machine learning of patients with COVID-19 over time: a large population-based cohort study in Mexico.
    Liao LD; Hubbard AE; Gutierrez JP; Juárez-Flores A; Kikkawa K; Gupta R; Yarmolich Y; de Jesús Ascencio-Montiel I; Bertozzi SM
    BMJ Open; 2023 Sep; 13(9):e072436. PubMed ID: 37739469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiology of COVID-19 in Mexico: from the 27th of February to the 30th of April 2020].
    Suárez V; Suarez Quezada M; Oros Ruiz S; Ronquillo De Jesús E
    Rev Clin Esp; 2020 Nov; 220(8):463-471. PubMed ID: 33994571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric COVID-19: Systematic review of the literature.
    Patel NA
    Am J Otolaryngol; 2020; 41(5):102573. PubMed ID: 32531620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of COVID-19 in Mexico: from the 27th of February to the 30th of April 2020.
    Suárez V; Suarez Quezada M; Oros Ruiz S; Ronquillo De Jesús E
    Rev Clin Esp (Barc); 2020 Nov; 220(8):463-471. PubMed ID: 32560915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.